Posts

Showing posts from December, 2018

Global Cold Plasma Market for Food and Agriculture Industry

According to the new market research report  " Cold Plasma Market  by Industry (Polymer, Textile, Electronics & Semiconductor, Food & Agriculture, Medical), Application (Coating, Adhesion, Finishing, Wound Healing, Decontamination), Regime (Atmospheric, Low-Pressure) - Global Forecast to 2021" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. In this report, the global market is segmented on the basis of Industrial application, regime, and region. On the basis of application, the textile industry market is further segmented into finishing, dyeing/printing, sterilization and others, the medical industry is further segmented into wound healing, cancer treatment, dentistry, blood coagulation and others, polymer & Plastic industry segment is further segmented into surface treatment, printing, adhesion and others, electronics & semiconductors industry is segmented into coating, fabricatio

Global Market Size For Pharmaceutical & Biotechnology Companies, By Region, 2014–2021 (USD Million)

According to the new market research report " In situ Hybridization Market by Technique (FISH, CISH), Application (Cancer Diagnosis, Neuroscience, Cytology, Infectious Disease), & End User (Molecular Diagnostic Laboratories, Academic And Research Institutions) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. The in situ hybridization market is projected to reach USD 739.9 Million by 2021 from USD 557.1 Million in 2016, at a CAGR of 5.8% in the next five years (2016 to 2021). In the coming years, the market is expected to witness the highest growth in the Asia-Pacific region. This can be attributed to the growing presence of international players in China and India, increasing cancer prevalence and diagnosis, and increased healthcare expenditure across the Asia-Pacific region are drivers for the in situ hybridization market in this region. North America is expected

Surgical Instruments Will Continue to Dominate the Lung Cancer Surgical Devices Market During the Forecast Period

Lung Cancer Surgery Market is segmented based on device, procedure, and region. On the basis of device, the market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment. In 2016, the surgical instrument segment is expected to account for the largest share of the market due to increasing prevalence of lung cancer and growing aging population. On the basis of procedure, the  Lung Cancer Surgery Market  is classified into thoracotomy and minimally invasive surgeries. The thoracotomy segment further sub segmented into lobectomy, sleeve resection, segmentectomy, and pneumonectomy. In 2016, the thoracotomy segment is expected to account for the largest share of the market. This large share can be attributed to increasing technological advancements in lung cancer treatment. Request Sample Report from Here  - https://www.marketsandmarkets.com/requestsampleNew.asp?id=222 The global market is segmented into four major regions—North America

High Throughput Process Development Automated Miniature Bioreactor System Market Size, By Region, 2014–2021 (USD Million)

The high throughput process development market is segmented on the basis of molecule type, end user, technology, product and service, and region. Based on molecule type, the market is classified into monoclonal antibodies and others (recombinant pro-insulin, polysaccharide vaccines, recombinant Green Fluorescent Protein (rGFP), fusion proteins, and interferon á-2a). The monoclonal antibodies segment accounted for the largest share of the global market in 2016. The large share of this segment is attributed to the increasing adoption of targeted immunotherapy and rising number of US FDA-cleared therapeutic monoclonal antibodies. Based on end user, the  High Throughput Process Development Market  is categorized into biopharmaceutical companies, contract research organizations and academic research institutes. Biopharmaceutical companies accounted for the largest share of the global high throughput process development market in 2016. The contract manufacturing organizations segment, on

Medical Bandages Market Size for Traumatic Wound Treatment, By Region, 2015–2022 (USD Million)

According to the new market research report  “ Medical Bandages Market by Product (Tapes (Fabric, Paper, Plastic), Bandage (Gauze, Adhesive, Cohesive & Elastic)), Application (Surgery, Trauma & Laceration, Ulcer, Sport, Burns), End User (Hospitals, ASCS, Clinics, Homecare) - Forecast to 2022" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). This report studies the global medical tapes and medical bandages market over the forecast period of 2017 to 2022. This market is projected to reach USD 7.39 Billion by 2022 from USD 6.13 Billion in 2017, at a CAGR of 3.8%. Factors such as rising number of surgeries, increasing incidence of chronic wounds, and rising geriatric population are driving the growth of the market. The global medical tapes and bandages market is projected to reach USD 7.39 Billion by 2022 from USD 6.13 Billion

Sperm Separation Systems Market, By Country/Region, 2015–2022 (USD Million)

According to the new market research report  “  In Vitro Fertilization Equipment Market  by Product (Imaging System, Incubator, Cabinets, Sperm Separation System, Cryopreservation media, Embryo Culture media), Type of Cycles & End Users (Fertility Clinics and Surgical Centres, Cryobanks) - Global Forecast to 2022" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global In vitro fertilization market is projected to be valued at USD 505.2 Million in 2017 and is expected to grow at a CAGR of 10.9% to reach to USD 847.8 Million by 2022. The key factors propelling the growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. Browse and in-depth TOC on  “In Vitro Fert

Global Key Players in the Neonatal Care Equipment Market

According to the new market research report  "Fetal (Labor & Delivery) and Neonatal Care Equipment Market Ultrasound, Doppler, Monitors (Intrapartum & Antepartum), Warmer, Incubator, Pulse Oximeter, Phototherapy/Jaundice Management Devices, CPAP, Capnograph, & Resuscitator) - Global Forecast to 2020" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world. This report studies the global fetal (labor & delivery) and  neonatal care equipment market  over the forecast period of 2015 to 2020. The market is estimated at USD 6.28 Billion in 2015 and is poised to grow at a CAGR of 6.5% during the forecast period, to reach USD 8.61 Billion by 2020. Request for Free Sample Report @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=412 Rising awareness among population in developing nations about neonatal and fetal care, g

Injection Pen Market for Diabetes Therapy, By Region, 2015–2022 (USD Million)

What are the Global Growth Factors? The global  injection pen market  growth is primarily driven by factors such as the growing prevalence of chronic diseases, increasing number of regulatory approvals, and favorable reimbursement in developed countries, and government support. What the Experts Says about the Market Growth? The   injection pen market  was valued at USD 29.47 Billion in 2016 and is projected to reach USD 41.38 Billion by 2022, at a CAGR of 6.0% during the forecast period. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022. Browse and in-depth TOC on “ Injection Pen Market ” 92 – Tables 28 - Figures 135 - Pages View more detailed TOC @  https://www.marketsandmarkets.com/Market-Reports/injection-pen-market-42342539.html The market is segmented on the basis of type, therapy, end user, and region. Based on type, the market is segmented into disposable and reusable injection pe

Neuroprosthetics Market worth 10.48 Billion USD by 2022

According to the new market research " Neuroprosthetics Market  by Type (Output (Cognitive, Motor Prosthetics), Input (Cochlear, Retinal Implant)), Techniques (Deep Brain, Vagus Nerve, Spinal Cord stimulation), Application (Epilepsy, Paralysis, Alzheimer’s Disease) - Global Forecast to 2022" published by MarketsandMarkets™. The neuroprosthetics market is expected to reach USD 10.48 Billion by 2022 from USD 5.84 Billion in 2017, at a CAGR of 12.4% from 2017 to 2022. Increasing number of neurological disorders, increasing incidence of hearing loss, increasing prevalence of diabetes, and increasing cases of amputation due to the rising number of accidents & injuries are major factors that are driving the growth of this market. Request for Free Sample Report  @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=234147399 The major factors driving the growth of this market can be attributed to the growth in funding and infrastructure development, advancements i

Efficacy Testing Market at CAGR of 8.7% - Global Forecast to 2022

According to the new market research report  " Efficacy Testing Market  by Product and Service (Consumables, Services), Type (Antimicrobial Efficacy Testing, Disinfectant Efficacy Testing), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products) - Global Forecast to 2022" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities. The global efficacy testing market is expected to reach USD 501.6 Million by 2022 from USD 330.5 Million in 2017, at a CAGR of 8.7%. The increasing government support for pharmaceutical and biotechnology industries and R&D investments in the pharmaceutical sector are the key factors driving the growth of this market. The global efficacy testing market is segmented by product and service, type, application, and region. By product and service, the market is segmented into consumables, services, and instruments. The consumables segment is estimated to ac